Clinical usefulness of dopamine transporter SPECT imaging with 123I-FP-CIT in patients with possible dementia with Lewy bodies: Randomised study

British Journal of Psychiatry

Volumn 206, Issue 2, 2015, Pages 145-152

  Walker, Zuzana ^a,b   Moreno, Emilio ^c   Thomas, Alan ^d   Inglis, Fraser ^e   Tabet, Naji ^f   Rainer, Michael ^g   Pizzolato, Gilberto ^h   Padovani, Alessandro ⁱ  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b North Essex Partnership University NHS Foundation Trust ^*  (United Kingdom)

^c GE HEALTHCARE   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e Glasgow Memory Clinic Ltd   (United Kingdom)

^f BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^g Memory Clinic und Karl Landsteiner Institut für Gedächtnis und Alzheimerforschung   (Austria)

^h UNIVERSITY OF TRIESTE   (Italy)

ⁱ UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IOFLUPANE I 123; DOPAMINE TRANSPORTER; IOFLUPANE; NORTROPANE DERIVATIVE;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; FEMALE; HUMAN; INJECTION SITE CONTUSION; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS; UNSPECIFIED SIDE EFFECT; BRAIN; CLINICAL TRIAL; DIAGNOSTIC USE; METABOLISM; PREDICTIVE VALUE; SCINTISCANNING;

AGED; BRAIN; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; NORTROPANES; PREDICTIVE VALUE OF TESTS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84923032877     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.114.148643     Document Type: Article

References (27)

1. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies - third report of the DLB consortium. Neurology 2005; 65: 1863-72.
2. O'Brien JT, McKeith IG, Walker Z, Tatsch K, Booij J, Darcourt J, et al. Diagnostic accuracy of I-123-FP-CIT SPECT in possible dementia with Lewy bodies. Br J Psychiatry 2009; 194: 34-9.
3. Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, et al. SIC Task force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003; 18: 467-86.
4. Nelson PT, Jicha GA, Kryscio RJ, Abner EL, Schmitt FA, Cooper G, et al. Low sensitivity in clinical diagnoses of dementia with Lewy bodies. J Neurology 2010; 257: 359-66.
5. Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, et al. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain 1999; 122: 1449-68.
6. Walker RWH, Walker Z. Dopamine transporter single photon emission computerized tomography in the diagnosis of dementia with Lewy bodies. Mov Disord 2009; 24: S754-S759.
7. Walker Z, Jaros E, Walker RWH, Lee L, Costa DC, Livingston G, et al. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. J Neurol Neurosurg Psychiatry 2007; 78: 1176-81.
8. McKeith I, O'Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, et al. Sensitivity and specificity of dopamine transporter imaging with (123)I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurology 2007; 6: 305-13.
9. Boot BP, McDade EM, McGinnis SM, Boeve BF. Treatment of dementia with Lewy bodies. Curr Treat Options Neurol 2013; 15: 738-64.
10. Ballard C, Grace J, McKeith I, Holmes C. Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease. Lancet 1998; 351: 1032-3.
11. Pakrasi S, Mukaetova-Ladinska EB, McKeith IG, O'Brien JT. Clinical predictors of response to acetyl cholinesterase inhibitors: experience from routine clinical use in Newcastle. Int J Geriatr Psychiatry 2003; 18: 879-86.
12. Matsunaga S, Kishi T, Iwata N. Memantine for Lewy body disorders: systematic review and meta-analysis. Am J Geriatr Psychiatry 2013 Dec 4 (Epub ahead of print).
13. Walker Z, McKeith I, Rodda J, Qassem T, Tatsch K, Booij J, et al. Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer's disease: a cohort study. BMJ Open 2012; 2: e000380.
14. Bostrom F, Jonsson L, Minthon L, Londos E. Patients with Lewy body dementia use more resources than those with Alzheimer's disease. Int J Geriatr Psychiatry 2007; 22: 713-9.
15. Bostrom F, Jonsson L, Minthon L, Londos E. Patients with dementia with Lewy bodies have more impaired quality of life than patients with Alzheimer disease. Alzheimer Dis Assoc Disord 2007; 21: 150-4.
16. Folstein MF, Folstein SE, Mchugh PR. Mini-Mental State - practical method for grading cognitive state of patients for clinician. J Psychiatric Res 1975; 12: 189-98.
17. Fahn S. Unified Parkinson's Disease Rating Scale. Recent Developments in Parkinson's Disease: 153-63. McMillan, 1987.
18. Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR. The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 2006; 21: 1078-85.
19. Cummings JL, Mega M, Gray K, Rosenbergthompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory - comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308-14.
20. Walker MP, Ayre GA, Cummings JL, Wesnes K, McKeith IG, O'Brien JT, et al. The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia. Br J Psychiatry 2000; 177: 252-6.
21. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): Recent Evidence and Development of a Shorter Version. Clinical Gerontology: A Guide to Assessment and Intervention: 165-73. The Haworth Press, 1986.
22. Filippi L, Manni C, Pierantozzi M, Brusa L, Danieli R, Stanzione P, et al. 123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms. Nucl Med Commun 2005; 26: 421-6.
23. Kemp PM, Clyde K, Holmes C. Impact of I-123-Fp-Cit (Datscan) Spect on the diagnosis and management of patients with dementia with Lewy bodies: a retrospective study. Nucl Med Commun 2011; 32: 298-302.
24. Morgan S, Kemp P, Booij J, Costa DC, Padayachee S, Lee L, et al. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT. J Neurol Neurosurg Psychiatry 2012; 83: 1063-70.
25. Colloby SJ, McParland S, O'Brien JT, Attems J. Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias. Brain 2012; 135: 2798-808.
26. Siepel FJ, Rongve A, Buter TC, Beyer MK, Ballard CG, Booij J, et al. (123I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study. BMJ Open 2013; 3: e002642.
27. National Institute for Health and Care Excellence. Supporting People with Dementia and their Carers in Health and Social Care. NICE Clinical Guideline 42. National Institute for Health and Care Excellence, 2006.